Evidence map›Paper›PMID 30430573›Full record

ArticleThe Journal of pathology2019

Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2.

Gonzalo Sánchez-Duffhues, Amaya García de Vinuesa, Vera van de Pol, Marlieke E Geerts, Margreet R de Vries, Stef Gt Janson, Hans van Dam, Jan H Lindeman, Marie-José Goumans, Peter Ten Dijke

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 198 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gonzalo Sánchez-DuffhuesDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-3205-0710
Amaya García de VinuesaDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Vera van de PolDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Marlieke E GeertsDepartment of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Margreet R de VriesDepartment of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Stef Gt JansonDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Hans van DamDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Jan H LindemanDepartment of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Marie-José GoumansDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Peter Ten DijkeDepartment of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial-to-mesenchymal transition (EndMT) has been unveiled as a common cause for a multitude of human pathologies, including cancer and cardiovascular disease. Vascular calcification is a risk factor for ischemic vascular disorders and slowing calcification may reduce mortality in affected patients. The absence of early biomarkers hampers the identification of patients at risk. EndMT and vascular calcification are induced upon cooperation between distinct stimuli, including inflammatory cytokines and transforming growth factor beta (TGF-β) family members. However, how these signaling pathways interplay to promote cell differentiation and eventually vascular calcification is not well understood. Using in vitro and ex vivo analysis in animal models and patient-derived tissues, we have identified that the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) induce EndMT in human primary aortic endothelial cells, thereby sensitizing them for BMP-9-induced osteogenic differentiation. Downregulation of the BMP type II receptor BMPR2 is a key event in this process. Rather than compromising BMP canonical signal transduction, loss of BMPR2 results in decreased JNK signaling in ECs, thus enhancing BMP-9-induced mineralization. Altogether, our results point at the BMPR2-JNK signaling axis as a key pathway regulating inflammation-induced EndMT and contributing to calcification. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Indexed as

AnimalsBone Morphogenetic Protein Receptors, Type IICell DifferentiationCells, CulturedDown-RegulationEndothelial CellsEndothelium, VascularEpithelial-Mesenchymal TransitionHumansInflammation MediatorsInterleukin-1betaMice, Inbred C3HOsteogenesisSignal TransductionTumor Necrosis Factor-alphaVascular CalcificationBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type IIIL1B protein, humanInflammation MediatorsInterleukin-1betaTumor Necrosis Factor-alphabone morphogenetic proteinc-Jun N-terminal kinaseendothelial cellendothelial-to-mesenchymal transitionfibroblastinflammationosteoblastpulmonary arterial hypertensiontransforming growth factor betatumor necrosis factor alphavascular calcification

Identifiers

PMID30430573
PMCPMC6590480
OpenAlexW2900846558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.